ILMN (ILMN) Stock Analysis

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $127.40
• Market Cap: $18.63B
• P/E Ratio: 22.57
• EPS: $5.40
• 52-Week High: $155.53
• 52-Week Low: $68.70

Market Sentiment

ILMN currently has a Bullish sentiment score of 0.18.

About ILMN

Illumina, Inc. is a prominent global leader in the biotechnology sector, headquartered in San Diego, California, and established in 1998. The company is renowned for its cutting-edge technologies and integrated systems for genomic analysis, with a strong focus on sequencing, genotyping, and gene expression solutions. Illumina's diverse product offerings cater to various markets, including research, clinical diagnostics, and agricultural genomics, significantly advancing the field of personali...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for ILMN and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ILMN pay dividends?

ILMN (ILMN) does not currently pay a regular dividend.

What is ILMN's P/E ratio?

ILMN has a price-to-earnings (P/E) ratio of 22.57.

What is ILMN's market cap?

ILMN (ILMN) has a market capitalization of $18.63B with a current stock price of $127.40.